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OBJECTIVE: Cost-effectiveness, -utility and -benefit
analyses have made a substantial impact on heath care.
Current approaches are methodologically coherent and
provide a basis for improved resource allocation. As has
been noted before, they are based on expected (average)
outcome and do not take into account patients’ risk pref-
erences, which are important aspects of clinical decision-
making. From a patient’s perspective, a treatment associ-
ated with a lower level of expected clinical benefit may be
preferred if it has better worst-case scenario than a treat-
ment with higher expected (average) benefit. We analyze
decision-scientific methodology in order to incorporate
risk preferences into the framework of outcome and util-
ity studies.
METHODS: Concepts of risk preferences in decision-
making from economics and management science are de-
scribed, and their applicability to a clinical context is
tested using a decision tree model. Methods analyzed in-
clude the Bayes-Principle of expected value (m-principle),
the m-s-principle, risk restriction with given outcome and
the Bernoulli-Principle. The absence of risk preferences in
the QALY (quality adjusted life years) and HYE (healthy
years equivalent) concepts is shown mathematically.
RESULTS: Current methodological concepts used in out-
comes research do not adequately incorporate patients’
risk preferences. On the basis of a modified standard
gamble approach a method of obtaining risk preferences
for given treatment outcome is developed. It leads to the
determination of relative marginal utilities and may be
used in choosing health-care interventions by considering
relative marginal costs.
CONCLUSION: Patients’ risk preferences should be taken
into account in outcome and utility analyses involving sub-
stantial risks. The approach proposed here may improve
the empirical estimation of patients’ preferences and the
quality of resource allocation in health care.
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OBJECTIVE: Support for the reliability and validity of
the Medical Outcomes Study (MOS) Sleep Scale was pro-
vided in the MOS sample of 3445 individuals with
chronic illness. We sought to extend this work by evalu-
ating the psychometric properties of the MOS-Sleep Scale
in the US general population.
METHODS: The MOS-Sleep Scale is a 12-item, self-re-
ported survey that yields six subscales: sleep disturbance,
snoring, awaken short of breath or with headache, quan-
tity of sleep, sleep adequacy, and somnolence as well as a
nine-item sleep problem index. The subscales and prob-
lem index are scored on a 0 to 100 range, with higher
scores indicating more of the domain being measured.
We administered the MOS measure by telephone to a na-
tionally representative sample of 1011 US adults aged 18
and older in January 2001.
RESULTS: The average age of the sample was 46; 51%
were female and 74% were white. Internal consistency
reliability estimates for the MOS-Sleep scales tended to
be adequate: sleep disturbance (4 items, alpha  0.80);
sleep adequacy (2 items, alpha  0.82); sleep somnolence
(3 items, alpha  0.63); and nine-item sleep problems in-
dex II (alpha  0.83). Adjusting for age and gender,
MOS patients reported significantly more quantity of
sleep (t  3.27, P  .002), but significantly worse sleep
disturbance (t  5.08, P  .001), snoring (t  2.16, P 
.05), shortness of breath (t  4.59, P  .001), sleep ade-
quacy (t  2.39, P  .05), somnolence (t  5.10, P 
.001), and sleep problems (t  3.27, P  .002) than the
general US population.
CONCLUSIONS: The MOS-Sleep Scale was found to
have good internal consistency reliability and to discrimi-
nate between patients with chronic illness and the US
general population. Further work is needed to compare
the MOS-Sleep Scale results with objective measures of
sleep such as polysomnography.
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OBJECTIVE: To analyze health-related quality of life
among people with sleeping problems from an epidemio-
logical perspective.
METHOD: A cross-sectional survey on a sample aged
between 20 and 84 years in the county of Uppland, Swe-
den yielded a response in 5404 patients (68%). A recall
period of two weeks was used for sleeping problems and
use of sleeping medication. The SF-36, used to measure
HRQoL, covers eight domains of health: physical func-
tion (PF); role limitation because of physical health (RP);
bodily pain (BP); general health perception (GH); vitality
(VT); social functioning (SF); role limitation because of
emotional health problem (RE), and mental health (MH).
Linear regression analysis was employed for the multi-
variate analyses.
RESULTS: In all, 20.3% of the population reported
sleeping problems. Sixteen percent had experienced sleep-
ing problems but had not used sleeping medication while
4.3% had used medication. The prevalence of sleeping
problems was of the same magnitude between the ages of
20 to 74 years (around 20%) but higher among those
aged 75 to 84 years (29.5%). Sleeping problems were
more prevalent among women (23.8%) than men (16.1%).
The use of sleeping medication increased by age. Among
